Allison B Resnick D.c. Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 5 Pequot Park Rd, Suite 201a, Westbrook, CT 06498 Phone: 860-391-8068 Fax: 860-391-8072 |
Dr. Thomas Leonard Kempinski Jr., D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 16 Westbrook Pl, Westbrook, CT 06498 Phone: 678-861-3424 |
News Archive
ClearWay Minnesota launched a new version of QUITPLAN Services, the free cessation program available to any Minnesotan who wants to quit tobacco. The new services now include free access to text messages, email support, a downloadable quit guide and free "starter kits," which provide a two-week supply of nicotine patches, gum or lozenges to help tobacco users quit.
The ninth Colloque Médecine et Recherche of la Fondation Ipsen devoted to Endocrinology, held in Paris on December 4, 2009, has reviewed the recent progress in understanding the regulation of fat storage in the body and the consequences of the breakdown of this regulation.
Alliqua, Inc., an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and wound care technologies today announced that it has acquired from Noble Biomaterials, Inc. a 10 year exclusive global license for two wound care dressings, with an additional 10 year renewal option.
High blood pressure, or hypertension, is a major problem worldwide, with the latest estimates suggesting that a billion people across the globe may have this condition. Hypertension not only takes an enormous cost on health and wellbeing, but it also exacts an expensive financial toll. Complications from this condition including kidney disease, and its resulting treatments, such as long-term dialysis and kidney transplant, are some of the costliest conditions the American health care system must contend with.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that positive microplasmin Phase II trial results, evaluating the product for the nonsurgical treatment of vitreomacular adhesion, have been published in the July/August issue of the journal Retina.
› Verified 2 days ago